gabexate has been researched along with Ovarian Neoplasms in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sakura, H | 1 |
| Fujii, T | 1 |
| Okamoto, K | 1 |
1 other study available for gabexate and Ovarian Neoplasms
| Article | Year |
|---|---|
A study of human calcitonin in an ovarian carcinoid and ovarian cancers.
Topics: Aprotinin; Benzamidines; Biomarkers, Tumor; Calcitonin; Carcinoid Tumor; Chromatography, Gel; Edetic | 1991 |